Eidos Therapeutics

About:

Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.

Website: http://eidostx.com

Twitter/X: eidostx

Top Investors: BridgeBio, RA Capital Management, Cormorant Asset Management, Perceptive Advisors, Viking Global Investors

Description:

BridgeBio is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients. The BridgeBio approach combines a traditional focus on drug development with a unique corporate model, allowing rapid translation of early stage science into medicines that treat disease at its source.